OTC Markets Group Inc. (OTCQX:OTCM) announced that Medicenna Therapeutics, a clinical-stage immunotherapy company, has upgraded from the OTCQB Venture Market to the OTCQX Best Market.
Medicenna begins trading on OTCQX under the symbol "MDNAF."
CEO Fahar Merchant expressed excitement, highlighting the move's role in enhancing liquidity and visibility among investors.